U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06890897) titled 'Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia' on March 12.
Brief Summary: To assess the 1-month effects and safety of esketamine combined PRF and standardized treatment to relieve pain in patients with acute/subacute zoster-related trigeminal neuralgia(ZRTN).
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Zoster; Herpes, Trigeminal Neuralgia (Etiology)
Intervention:
DRUG: Esketamine group
Patients in the esketamine group will receive intravenous infusion of esketamine besides PRF+standardized treatment.The formula will be intravenous infusion of 0.5mg/k...